AbbVie to Host Second-Quarter 2025 Earnings Conference Call
AbbVie (NYSE: ABBV) has scheduled its second-quarter 2025 financial results announcement for Thursday, July 31, 2025, before market opening. The company will host a live earnings conference call at 8 a.m. Central time. Investors can access the webcast through AbbVie's Investor Relations website at investors.abbvie.com, with an archived version available later that day.
AbbVie (NYSE: ABBV) ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per giovedì 31 luglio 2025, prima dell'apertura dei mercati. La società terrà una conference call in diretta sui risultati alle 8:00 ora centrale. Gli investitori potranno seguire la trasmissione in streaming sul sito delle Relazioni con gli Investitori di AbbVie all'indirizzo investors.abbvie.com, con una versione registrata disponibile più tardi nella giornata.
AbbVie (NYSE: ABBV) ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el jueves 31 de julio de 2025, antes de la apertura del mercado. La empresa realizará una conferencia telefónica en vivo sobre las ganancias a las 8 a.m., hora central. Los inversores pueden acceder a la transmisión en vivo a través del sitio web de Relaciones con Inversores de AbbVie en investors.abbvie.com, con una versión archivada disponible más tarde ese mismo día.
AbbVie (NYSE: ABBV)는 2025년 2분기 재무 실적 발표를 2025년 7월 31일 목요일, 시장 개장 전으로 예정했습니다. 회사는 중부 시간 오전 8시에 실적 관련 라이브 컨퍼런스 콜을 진행할 예정입니다. 투자자들은 AbbVie 투자자 관계 웹사이트 investors.abbvie.com을 통해 웹캐스트에 접속할 수 있으며, 같은 날 나중에 녹화본도 제공됩니다.
AbbVie (NYSE : ABBV) a prévu d’annoncer ses résultats financiers du deuxième trimestre 2025 le jeudi 31 juillet 2025, avant l’ouverture des marchés. La société organisera une conférence téléphonique en direct sur les résultats à 8 heures, heure centrale. Les investisseurs pourront accéder à la webdiffusion via le site des relations investisseurs d’AbbVie à l’adresse investors.abbvie.com, avec une version enregistrée disponible plus tard dans la journée.
AbbVie (NYSE: ABBV) hat die Bekanntgabe der Finanzergebnisse für das zweite Quartal 2025 für Donnerstag, den 31. Juli 2025, vor Börsenöffnung geplant. Das Unternehmen wird um 8 Uhr Central Time eine Live-Konferenzschaltung zur Ergebnisbesprechung abhalten. Investoren können den Webcast über die Investor-Relations-Website von AbbVie unter investors.abbvie.com verfolgen; eine Aufzeichnung wird später am Tag verfügbar sein.
- None.
- None.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
Media: Gabby Tarbert | Investors: Liz Shea |
View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-host-second-quarter-2025-earnings-conference-call-302493406.html
SOURCE AbbVie
FAQ
When will AbbVie (ABBV) report Q2 2025 earnings?
What time is AbbVie's Q2 2025 earnings conference call?
How can investors access AbbVie's Q2 2025 earnings call?
Will AbbVie's Q2 2025 earnings call be available for replay?
